All material subject to strictly enforced copyright laws. © 2021 Euromoney Institutional Investor PLC group
Asia EquityAsia IPOs

Hong Kong bourse returns Aim Vaccine’s IPO application


Hong Kong’s stock exchange has rejected an IPO application from Aim Vaccine, a leading Chinese vaccine maker. The deal is being sponsored by China Securities, CICC, Goldman Sachs and Macquarie.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree